[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366461-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366461-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","altered-glycosylation-of-psa-in-prostate-cancer-tissue","Altered Glycosylation of PSA in Prostate Cancer Tissue","","Protein glycosylation is frequently altered in cancer and can enable new biomarker development. As prostate-specific antigen (PSA) is a glycoprotein, cancer-specific PSA glycoforms are a promising diagnostic and prognostic target. PSA glycoforms were analyzed directly in prostate tissues using an in situ proximity-ligation assay with a PSA-specific antibody and 25 lectins. Cancer tissues showed lectin-detected glycoforms enriched versus matched benign regions, with implications for a future serum diagnostic test.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/altered-glycosylation-of-psa-in-prostate-cancer-tissue/366461/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/altered-glycosylation-of-psa-in-prostate-cancer-tissue/366461.png","ImageObject",300,407,{"name":42,"@type":43},"McGucket","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about PSA in prostate cancer?","Question",{"text":63,"@type":64},"The study evaluates whether PSA glycosylation changes within prostate cancer tissue and whether cancer-specific PSA glycoforms can be detected in situ.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were PSA glycoforms detected in the tissue samples?",{"text":68,"@type":64},"PSA glycoforms were detected in tissues using an in situ proximity-ligation assay with a PSA-specific antibody and 25 different glycan-binding lectins.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings regarding PSA glycoforms in cancer versus benign tissue?",{"text":72,"@type":64},"Using lectins such as succinylated wheat germ (WGAsucc) and Vicia villosa (VVA), the PSA glycoforms were enriched in cancerous tissues compared with adjacent matched benign tissues.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366461,1790200177,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","The Prostate  \nORIGINAL ARTICLE   \nAltered Glycosylation of PSA in Prostate Cancer Tissue  \nHannu Koistinen1  | Ruusu‐Maaria Merivirta1,2,3  | Timo‐Pekka Lehto2,3,4 | Anna Lempiäinen1 | Andrew Erickson2,5 | Ulf‐Håkan Stenman1 | Antti Rannikko2,4 | Tuomas Mirtti2,3,6  \n1Department of Clinical Chemistry and Haematology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland | 2Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland | 3Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland | 4Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland | 5iCAN Digital Precision Cancer Medicine  \nFlagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland | 6Finnish Cancer Institute, Helsinki, Finland Correspondence: Hannu Koistinen ([hannu.k.koistinen@helsinki.fi](hannu.k.koistinen@helsinki.fi))  \nReceived: 20 May 2025 | Revised: 20 June 2025 | Accepted: 3 July 2025  \nFunding: This study was supported by grants from Sigrid Jusélius Foundation (Hannu Koistinen, Tuomas Mirtti, Andrew Erickson), Cancer Foundation Finland (Andrew Erickson, Tuomas Mirtti, Antti Rannikko), Finnish Cancer Institute (Tuomas Mirtti), Finnish Society of Sciences and Letters (Hannu Koistinen), Magnus Ehrnrooth Foundation (Hannu Koistinen), Finnish Society of Clinical Chemistry (Hannu Koistinen), Laboratoriolääketieteen edistämissäätiö (Hannu Koistinen), Research Council of Finland (Andrew Erickson, Antti Rannikko), Instrumentarium Science Foundation (Andrew Erickson grant), Digital Precision Cancer Medicine Flagship iCAN (Andrew Erickson), Faculty of Medicine University of Helsinki (Andrew Erickson), Jane and Aatos Erkko Foundation (Antti Rannikko), Helsinki University Hospital research funds (Anna Lempiäinen, Hannu Koistinen, Tuomas Mirtti) and State funding for university level health research (Tuomas Mirtti, Antti Rannikko) .  \nKeywords: glycosylation | in situ proximity ligation | lectin | prostate cancer | PSA  \nABSTRACT  \nBackground: The glycosylation of proteins is commonly altered in cancer. This offers novel opportunities for cancer biomarker development. As prostate‐specific antigen (PSA) is a glycoprotein, identification of cancer‐specific PSA‐glycoforms is feasible. Such PSA‐glycoforms may provide valuable diagnostic and prognostic information.  \nMethods: PSA‐glycoforms were studied in tissues, using in situ proximity‐ligation assay (PLA)‐based detection with a PSA‐specific antibody and 25 different glycan‐binding lectins.  \nResults: Using 25 different lectins and a small tissue microarray (TMA), we showed that glycosylation of PSA in cancerous tissues is different from that in benign prostate. In a larger TMA with samples from 162 patients, PSA‐glycoforms detected by succinylated wheat germ (WGAsucc) and Vicia villosa (VVA) lectins were enriched in cancerous tissues as compared to adjacent benign tissues from the same patients (p \u003C10−4 for both, Kruskal–Wallis H test), although strong total PSA staining was more often found in benign tissues (p = 6*10−14) .  \nConclusions: We showed here that glycosylation of PSA is changed in situ in prostate cancer. The identified lectins, showing preferential binding to cancer‐associated PSA‐glycoforms, will aid the future development of a diagnostic serum test of prostate cancer. Such a test has potential to revolutionize prostate cancer diagnostics.  \n1 | Introduction  \nProstate‐specific antigen (PSA) blood test is often able to identify prostate cancers at an early stage and PSA‐based screening has been found to reduce prostate cancer‐specific mortality [1–3] . However, PSA levels in blood circulation can increase in  \nmen with benign prostatic hyperplasia (BPH) or prostatitis as well as in patients with clinically insignificant cancers [1–5] . The diagnostic accuracy of the PSA test can be improved by analyzing total PSA jointly with other biomarkers or dif","cbCaijJodCf2qiak","https://ap.wps.com/l/cbCaijJodCf2qiak","pdf",1109445,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Introduction","[{\"question\":\"What question does the study address about PSA in prostate cancer?\",\"answer\":\"The study evaluates whether PSA glycosylation changes within prostate cancer tissue and whether cancer-specific PSA glycoforms can be detected in situ.\"},{\"question\":\"How were PSA glycoforms detected in the tissue samples?\",\"answer\":\"PSA glycoforms were detected in tissues using an in situ proximity-ligation assay with a PSA-specific antibody and 25 different glycan-binding lectins.\"},{\"question\":\"What were the key findings regarding PSA glycoforms in cancer versus benign tissue?\",\"answer\":\"Using lectins such as succinylated wheat germ (WGAsucc) and Vicia villosa (VVA), the PSA glycoforms were enriched in cancerous tissues compared with adjacent matched benign tissues.\"}]","Altered Glycosylation of PSA in Prostate Cancer Tissue | PDF",1790165669,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f3a95e1b24eedcd9f88933acb292ac6.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6aa7ff144933e8185806a7f56e8030a5.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/575a7a82e1469fb46a8262a242b90d0f.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/840672aed40eaeb91fcbe6611dda8ca9.webp",980,1287]